Related Experiment Video
Updated: Feb 3, 2026

Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Increased FDG Uptake and Chronic Lung Changes in a Case of Persistent Lipoid Pneumonia
Kianoush Ansari-Gilani1, Navid Faraji, Robert C Gilkeson
1From the Department of Diagnostic Radiology, University Hospitals Cleveland Medical Center, Cleveland, OH.
Abstract:
Lipoid pneumonia is uncommon disease caused by presence of macroscopic fat in the lung parenchyma commonly originating from exogenous source secondary to aspiration or inhalation of animal fats or mineral or vegetable oils. Alternatively, it can be due to endogenous fat accumulated in the alveoli in the setting of chronic bronchial obstruction or inflammation. The imaging findings include ground-glass opacities, consolidation, nodules, and masses. Presence of macroscopic fat on CT is helpful; however it might not always be present. Increased FDG uptake can be present secondary to ongoing inflammation mimicking malignancy. Tissue diagnosis might be needed in some cases.
Insights
Lipoid pneumonia, caused by fat in the lungs from external or internal sources, presents with varied imaging findings. Diagnosis may require tissue analysis when CT scans are inconclusive.
Area of Science:
- Pulmonology
- Radiology
- Pathology
Background:
- Lipoid pneumonia is a rare lung disease characterized by the presence of macroscopic fat in lung tissue.
- It can stem from exogenous sources (animal fats, oils) or endogenous fat accumulation due to chronic airway issues.
- Imaging may show ground-glass opacities, consolidation, nodules, or masses.
Related Concept Videos
Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Pneumonia II: Pathophysiology
Increasing Function
Lung Capacity
Pneumonia IV: Management
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Increased Body Temperature

